Delivery Order SPE2DB22D3501-SPE2DB25FUV37

Award Date 3/7/25
Potential Completion Date 3/28/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,129.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the procurement of Pfizer COVID-19 vaccines, with a period of performance from February 2025 to March 2025. The contract is a firm fixed-price arrangement and was not designated as a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $3,407.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 timeframe, with a period of performance through November 18, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designations, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of Pfizer's COVID-19 vaccine over a period of 6 months to 4 years, under an Emergency Use Authorization. The $2,259.62 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen has a significant Indefinite Delivery Contract...
This federal contract award, with a ceiling value of $1,129.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of COVID-19 vaccines, specifically Pfizer's COVID-19 vaccine, with an ultimate completion date of December 27, 2024. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award is a delivery order valued at $1,622.03, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pfizer COVID-19 vaccines and related medical products, including 0.9ML vials, to support military healthcare programs from 2024 to 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.80 firm fixed-price delivery order is for the procurement of Pfizer COVID-19 vaccine doses, with an ultimate completion date of December 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,642.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccines, with an ultimate completion date of November 19, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is a Child contract under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $7,569.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
This federal contract award, valued at $1,081.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccines in 0.9 mL doses, with an ultimate completion date of March 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines. The contract has a ceiling value of $1,129.80 and a completion date of February 19, 2025. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUV37
    Delivery Order

This federal contract award, valued at $2,200.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccines with a period of performance running through March 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and covering a comprehensive range of pharmaceutical and medical supply products. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive experience and capabilities in the distribution of critical medical commodities, including specialty medications, vaccines, and other essential supplies, make it a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems.

Generated 6/6/25, 10:11 AM